Action LAM IND
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Communiqués LAM IND Other OTC

Actions

US51280R1041

Cours en clôture Other OTC
Autres places de cotation
- USD - Graphique intraday de LAM IND
2021 Parallel Industries Inc. annonce ses résultats pour le troisième trimestre clos le 30 septembre 2021 CI

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
EASTON PHARMACEUTICALS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q/A)
AQ
EASTON PHARMACEUTICALS INC. - 10-K/A - Management's Discussion and Analysis of Financial Condition and Results of Operations.
AQ
EASTON PHARMACEUTICALS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
EASTON PHARMACEUTICALS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
EASTON PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
Easton Pharmaceuticals Turns to Profit in Q1, Provides Business Update
GL
Easton Signs Agreement to Acquire Commercial Bakery with Projected Revenues Over $20,000,000 per Year and Positioned to Enter the Cannabis Edibles Market
GL
Easton Announces Updates on Its $2,600,000 Framing Contract to Construct 150 Homes as Well as Other Initiatives
GL
Easton Announces Completion of Financial Statements With $200,000 in Sales in Quarter Ending Sept. 30th, 2018 and Revenue for Quarter Ending December 31, 2018
GL
Easton Announces Status Updates on its $2,600,000 Framing Contract to Construct 150 Homes, Including New Additional Project
GL
Easton Pharmaceuticals Announces Signing and Commencement of $2,600,000 Framing Contract to Construct 150 Homes
GL
Easton Pharmaceuticals Completes Purchase of Development Project with Total Projected Profit in Excess of $30 Million
GL
Easton Pharmaceuticals Provides Company Update Including Hotel Acquisition in Toronto, BAYER Agreement and Casino Resort in Greece
GL
Easton Pharmaceuticals Is Short-Listed to Acquire an Interest in an Operating Casino and Hotel Resort in Loutraki, Greece with Revenues in Excess of 60 Million Euro Per Year
GL
Easton Pharmaceuticals Reaches Agreement to Take Over Hotel and $17,000,000 Real Estate Asset in Heart of Toronto, Canada
GL
Easton Pharmaceuticals to Participate in a Casino and Hotel Resort Project in Europe with Projected Revenues in Excess of 77 Million Euro Per Annum
GL
Easton Pharmaceuticals Acquires Interest in Development Project With in Excess of $30 Million in Profit
GL
Easton Pharmaceuticals Strengthens its Board of Directors While Enhancing Existing Businesses and Moves Towards New Sectors and Industries
GL
Easton Pharmaceuticals Announces New Director / Officer to Its Board and Updates to Business Direction
GL
Easton Pharmaceuticals Announces That Easton and Its JV Partner, Alliance Group, Have Generated $40,000 in Revenues in the First Week of Operations
GL
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action EAPH
  4. Action
  5. Actualités LAM IND
  6. Communiqués